Huang Hailiang, Fang Ming, Jostins Luke, Umićević Mirkov Maša, Boucher Gabrielle, Anderson Carl A, Andersen Vibeke, Cleynen Isabelle, Cortes Adrian, Crins François, D'Amato Mauro, Deffontaine Valérie, Dmitrieva Julia, Docampo Elisa, Elansary Mahmoud, Farh Kyle Kai-How, Franke Andre, Gori Ann-Stephan, Goyette Philippe, Halfvarson Jonas, Haritunians Talin, Knight Jo, Lawrance Ian C, Lees Charlie W, Louis Edouard, Mariman Rob, Meuwissen Theo, Mni Myriam, Momozawa Yukihide, Parkes Miles, Spain Sarah L, Théâtre Emilie, Trynka Gosia, Satsangi Jack, van Sommeren Suzanne, Vermeire Severine, Xavier Ramnik J, Weersma Rinse K, Duerr Richard H, Mathew Christopher G, Rioux John D, McGovern Dermot P B, Cho Judy H, Georges Michel, Daly Mark J, Barrett Jeffrey C
Analytic and Translational Genetics Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02141, USA.
Nature. 2017 Jul 13;547(7662):173-178. doi: 10.1038/nature22969. Epub 2017 Jun 28.
Inflammatory bowel diseases are chronic gastrointestinal inflammatory disorders that affect millions of people worldwide. Genome-wide association studies have identified 200 inflammatory bowel disease-associated loci, but few have been conclusively resolved to specific functional variants. Here we report fine-mapping of 94 inflammatory bowel disease loci using high-density genotyping in 67,852 individuals. We pinpoint 18 associations to a single causal variant with greater than 95% certainty, and an additional 27 associations to a single variant with greater than 50% certainty. These 45 variants are significantly enriched for protein-coding changes (n = 13), direct disruption of transcription-factor binding sites (n = 3), and tissue-specific epigenetic marks (n = 10), with the last category showing enrichment in specific immune cells among associations stronger in Crohn's disease and in gut mucosa among associations stronger in ulcerative colitis. The results of this study suggest that high-resolution fine-mapping in large samples can convert many discoveries from genome-wide association studies into statistically convincing causal variants, providing a powerful substrate for experimental elucidation of disease mechanisms.
炎症性肠病是一种慢性胃肠道炎症性疾病,影响着全球数百万人。全基因组关联研究已经确定了200个与炎症性肠病相关的基因座,但很少有基因座能最终确定为特定的功能变异。在此,我们报告了在67852名个体中使用高密度基因分型对94个炎症性肠病基因座进行的精细定位。我们以大于95%的确定性将18个关联定位到单个因果变异,另外以大于50%的确定性将27个关联定位到单个变异。这45个变异在蛋白质编码变化(n = 13)、转录因子结合位点的直接破坏(n = 3)和组织特异性表观遗传标记(n = 10)方面显著富集,最后一类在克罗恩病中较强的关联中在特定免疫细胞中显示富集,在溃疡性结肠炎中较强的关联中在肠道黏膜中显示富集。本研究结果表明,在大样本中进行高分辨率精细定位可以将全基因组关联研究中的许多发现转化为具有统计学说服力的因果变异,为疾病机制的实验阐明提供有力基础。